Objective: To evaluate the safety and pharmacokinetics of YKP3089

Inclusion criteria

  • Age 14-65
  • Diagnosis of refractory focal epilepsy. No exact seizure frequency required.
  • Treated with at least one AED in the last 2


Exclusion criteria

  • History of any drug-induced rash or hypersensitivity reaction.


Mid-Atlantic Epilepsy & Sleep Center
Pavel Klein, M.D.

Ivana Tyrlikova, Arkady Barber, Lenka Goldman, study coordinators
Phone: 301 530 9744
Fax: 301 530 0046